We serve Chemical Name:cis-4-Hydroxy Tamoxifen Discontinued CAS:174592-47-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:cis-4-Hydroxy Tamoxifen Discontinued
CAS.NO:174592-47-3
Synonyms:4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
Molecular Formula:C26H29NO2
Molecular Weight:387.51400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:514.4ºC at 760 mmHg
Density:1.092g/cm3
Index of Refraction:1.596
PSA:32.70000
Exact Mass:387.22000
LogP:5.70170
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol Use and application,4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol technical grade,usp/ep/jp grade.
Related News: It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. cis-4-Hydroxy Tamoxifen Discontinued manufacturer The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. cis-4-Hydroxy Tamoxifen Discontinued supplier In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. cis-4-Hydroxy Tamoxifen Discontinued vendor In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. cis-4-Hydroxy Tamoxifen Discontinued factory In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo.
